Open Access
Open access
Chemical Science, volume 12, issue 7, pages 2667-2673

Photoactivatable prodrug for simultaneous release of mertansine and CO along with a BODIPY derivative as a luminescent marker in mitochondria: a proof of concept for NIR image-guided cancer therapy

Tiwari Rajeshwari 1, 2
Shinde Prashant S 3
Sreedharan Sreejesh 4
Dey Anik Kumar 1, 2
VALLIS K. A. 4
Mhaske Santosh B 2, 3
Pramanik Sumit Kumar 1, 2
Das Amitava 5
Publication typeJournal Article
Publication date2021-01-01
Journal: Chemical Science
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor8.4
ISSN20416520, 20416539
PubMed ID:  34164035
General Chemistry
Abstract
Controlled and efficient activation is the crucial aspect of designing an effective prodrug. Herein we demonstrate a proof of concept for a light activatable prodrug with desired organelle specificity. Mertansine, a benzoansamacrolide, is an efficient microtubule-targeting compound that binds at or near the vinblastine-binding site in the mitochondrial region to induce mitotic arrest and cell death through apoptosis. Despite its efficacy even in the nanomolar level, this has failed in stage 2 of human clinical trials owing to the lack of drug specificity and the deleterious systemic toxicity. To get around this problem, a recent trend is to develop an antibody-conjugatable maytansinoid with improved tumor/organelle-specificity and lesser systematic toxicity. Endogenous CO is recognized as a regulator of cellular function and for its obligatory role in cell apoptosis. CO blocks the proliferation of cancer cells and effector T cells, and the primary target is reported to be the mitochondria. We report herein a new mitochondria-specific prodrug conjugate (Pro-DC) that undergoes a photocleavage reaction on irradiation with a 400 nm source (1.0 mW cm−2) to induce a simultaneous release of the therapeutic components mertansine and CO along with a BODIPY derivative (BODIPY(PPH3)2) as a luminescent marker in the mitochondrial matrix. The efficacy of the process is demonstrated using MCF-7 cells and could effectively be visualized by probing the intracellular luminescence of BODIPY(PPH3)2. This provides a proof-of-concept for designing a prodrug for image-guided combination therapy for mainstream treatment of cancer.

Citations by journals

1
2
Coordination Chemistry Reviews
Coordination Chemistry Reviews, 2, 9.52%
Coordination Chemistry Reviews
2 publications, 9.52%
Chemical Science
Chemical Science, 2, 9.52%
Chemical Science
2 publications, 9.52%
ChemBioChem
ChemBioChem, 2, 9.52%
ChemBioChem
2 publications, 9.52%
Molecules
Molecules, 1, 4.76%
Molecules
1 publication, 4.76%
ChemistrySelect
ChemistrySelect, 1, 4.76%
ChemistrySelect
1 publication, 4.76%
Foods
Foods, 1, 4.76%
Foods
1 publication, 4.76%
Journal of the Indian Chemical Society, 1, 4.76%
Journal of the Indian Chemical Society
1 publication, 4.76%
Dyes and Pigments
Dyes and Pigments, 1, 4.76%
Dyes and Pigments
1 publication, 4.76%
European Journal of Medicinal Chemistry Reports
European Journal of Medicinal Chemistry Reports, 1, 4.76%
European Journal of Medicinal Chemistry Reports
1 publication, 4.76%
Bioconjugate Chemistry
Bioconjugate Chemistry, 1, 4.76%
Bioconjugate Chemistry
1 publication, 4.76%
Chemical Communications
Chemical Communications, 1, 4.76%
Chemical Communications
1 publication, 4.76%
Journal of Materials Chemistry B
Journal of Materials Chemistry B, 1, 4.76%
Journal of Materials Chemistry B
1 publication, 4.76%
Nanoscale Advances
Nanoscale Advances, 1, 4.76%
Nanoscale Advances
1 publication, 4.76%
Antioxidants
Antioxidants, 1, 4.76%
Antioxidants
1 publication, 4.76%
TrAC - Trends in Analytical Chemistry
TrAC - Trends in Analytical Chemistry, 1, 4.76%
TrAC - Trends in Analytical Chemistry
1 publication, 4.76%
Angewandte Chemie
Angewandte Chemie, 1, 4.76%
Angewandte Chemie
1 publication, 4.76%
Angewandte Chemie - International Edition
Angewandte Chemie - International Edition, 1, 4.76%
Angewandte Chemie - International Edition
1 publication, 4.76%
Biomolecules
Biomolecules, 1, 4.76%
Biomolecules
1 publication, 4.76%
1
2

Citations by publishers

1
2
3
4
5
Wiley
Wiley, 5, 23.81%
Wiley
5 publications, 23.81%
Elsevier
Elsevier, 5, 23.81%
Elsevier
5 publications, 23.81%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 5, 23.81%
Royal Society of Chemistry (RSC)
5 publications, 23.81%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 4, 19.05%
Multidisciplinary Digital Publishing Institute (MDPI)
4 publications, 19.05%
Scientific Publishers, 1, 4.76%
Scientific Publishers
1 publication, 4.76%
American Chemical Society (ACS)
American Chemical Society (ACS), 1, 4.76%
American Chemical Society (ACS)
1 publication, 4.76%
1
2
3
4
5
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Tiwari R. et al. Photoactivatable prodrug for simultaneous release of mertansine and CO along with a BODIPY derivative as a luminescent marker in mitochondria: a proof of concept for NIR image-guided cancer therapy // Chemical Science. 2021. Vol. 12. No. 7. pp. 2667-2673.
GOST all authors (up to 50) Copy
Tiwari R., Shinde P. S., Sreedharan S., Dey A. K., VALLIS K. A., Mhaske S. B., Pramanik S. K., Das A. Photoactivatable prodrug for simultaneous release of mertansine and CO along with a BODIPY derivative as a luminescent marker in mitochondria: a proof of concept for NIR image-guided cancer therapy // Chemical Science. 2021. Vol. 12. No. 7. pp. 2667-2673.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1039/D0SC06270G
UR - https://doi.org/10.1039%2FD0SC06270G
TI - Photoactivatable prodrug for simultaneous release of mertansine and CO along with a BODIPY derivative as a luminescent marker in mitochondria: a proof of concept for NIR image-guided cancer therapy
T2 - Chemical Science
AU - Tiwari, Rajeshwari
AU - Shinde, Prashant S
AU - Sreedharan, Sreejesh
AU - Dey, Anik Kumar
AU - VALLIS, K. A.
AU - Mhaske, Santosh B
AU - Pramanik, Sumit Kumar
AU - Das, Amitava
PY - 2021
DA - 2021/01/01 00:00:00
PB - Royal Society of Chemistry (RSC)
SP - 2667-2673
IS - 7
VL - 12
PMID - 34164035
SN - 2041-6520
SN - 2041-6539
ER -
BibTex |
Cite this
BibTex Copy
@article{2021_Tiwari,
author = {Rajeshwari Tiwari and Prashant S Shinde and Sreejesh Sreedharan and Anik Kumar Dey and K. A. VALLIS and Santosh B Mhaske and Sumit Kumar Pramanik and Amitava Das},
title = {Photoactivatable prodrug for simultaneous release of mertansine and CO along with a BODIPY derivative as a luminescent marker in mitochondria: a proof of concept for NIR image-guided cancer therapy},
journal = {Chemical Science},
year = {2021},
volume = {12},
publisher = {Royal Society of Chemistry (RSC)},
month = {jan},
url = {https://doi.org/10.1039%2FD0SC06270G},
number = {7},
pages = {2667--2673},
doi = {10.1039/D0SC06270G}
}
MLA
Cite this
MLA Copy
Tiwari, Rajeshwari, et al. “Photoactivatable prodrug for simultaneous release of mertansine and CO along with a BODIPY derivative as a luminescent marker in mitochondria: a proof of concept for NIR image-guided cancer therapy.” Chemical Science, vol. 12, no. 7, Jan. 2021, pp. 2667-2673. https://doi.org/10.1039%2FD0SC06270G.
Found error?